Toxoplasmosis is a common infection whose clinical severity can sometimes justify admission to intensive care, especially in immunocompromised patients.
This study should make it possible to evaluate the impact of different anti-infective treatment regimens and to highlight clinical-biological and prognostic differences depending on the type of underlying immunosuppression.
Adult patient hospitalized in intensive care
At least 1 organ failure (SOFA> or =2)
PCR toxoplasmosis on CSF, blood, BAL, or bone marrow positive within 7 days before or after admission to ICU
Post-mortem diagnosis
Primary outcome not available
Patient living informed and not opposed to the reuse of their data in this research.